Operating Segments (Details)	3 Months Ended
	Mar. 31, 2022 USD ($) segment	Mar. 31, 2021 USD ($)	Dec. 31, 2021 USD ($)
Segment reporting
Revenues	$ 188,063	$ 147,593
Loss from operations	(4,202,628)	(2,233,607)
Amortization and depreciation	8,232	8,899
Other (Expense)/Income, Net	(146,393)	(128,871)
Share-based compensation	78,271	94,805
Identifiable Assets	$ 23,674,644		$ 26,869,927
Operating segments | segment	2
Public Health Solutions [Member]
Segment reporting
Revenues	$ 188,063	147,593
Loss from operations	(120,621)	(130,781)
Amortization and depreciation	436	316
Share-based compensation	1,054	6,295
Identifiable Assets	223,895		128,645
Specialized BioTherapeutics [Member]
Segment reporting
Loss from operations	(1,539,728)	(1,112,408)
Amortization and depreciation	2,614	1,899
Other (Expense)/Income, Net	55,079	84,634
Share-based compensation	28,504	29,579
Identifiable Assets	132,921		146,296
Corporate [Member]
Segment reporting
Loss from operations	(2,542,279)	(990,418)
Amortization and depreciation	5,182	6,684
Other (Expense)/Income, Net	(201,472)	(213,505)
Share-based compensation	48,713	$ 58,931
Identifiable Assets	$ 23,317,828		$ 26,594,986